The Same Problems Persist for Ocugen in Marketing Covaxin
The latest news that Ocugen (NASDAQ:OCGN) is moving closer toward emergency use authorization for its Covid-19 vaccine candidate is moving its stock. On May 25 the company submitted its master file to the Food...